SAIMSARA Journal

Machine-Readable Science • ISSN 3054-3991

Phlegmasia Cerulea Dolens and Massive DVT: Scoping Review with ☸️SAIMSARA.

Cardiac & Vascular Health icon

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

Chat with this issue

DOI: 10.62487/saimsara53caab39

Editorial note
• Last update: 2026-05-15 21:22:16
What is this paper about
Phlegmasia cerulea dolens is a rare but catastrophic venous emergency where delayed recognition can mean shock, venous gangrene, amputation, or death. This SAIMSARA evidence map is worth reading because it separates real treatment signals from case-level noise, mapping anticoagulation, thrombolysis, thrombectomy, stenting, fasciotomy, complications, and high-risk contexts across the full clinical spectrum.
Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.
Found an issue in this paper? Email admin@saimsara.com


saimsara.com

Abstract: To synthesize the original clinical literature captured for the query “phlegmasia cerulea dolens,” focusing on study characteristics, recurrent disease-defining findings, clinical contexts, management patterns, complications, and implications for diagnosis, treatment selection, and future research. The review uses 121 references and builds its evidence map from 126 original studies with 249 total participants/sample observations (topic-deduplicated ΣN). The synthesized evidence indicates that phlegmasia cerulea dolens is best understood as a time-sensitive venous outflow emergency in which early recognition, prompt anticoagulation, and individualized escalation to clot-reduction therapy are central to limb and life salvage. The most consistent result-level signal supports a role for endovenous debulking and pharmacomechanical strategies, with one 144-patient literature-based retrospective analysis reporting a 70% reduction in amputation/death with endovenous debulking compared with anticoagulation or thrombectomy, although outcomes remained heterogeneous and serious complications including reperfusion injury, acute kidney injury, and fatal embolism were repeatedly reported. Because the underlying evidence is dominated by case-level reports, certainty about comparative effectiveness across thrombolytic, mechanical, surgical, and hybrid pathways remains limited. Future work should prioritize prospective multicenter registries with standardized severity definitions and shared endpoints to benchmark escalation pathways and clarify which patients benefit most from aggressive venous intervention.

Keywords: Phlegmasia cerulea dolens; Deep vein thrombosis; Iliofemoral thrombosis; Venous gangrene; Mechanical thrombectomy; Catheter-directed thrombolysis; Anticoagulation; Limb salvage; Compartment syndrome; Malignancy

Review Stats

Get access to the full paper

Unlock the full evidence map

Full paper access includes the complete human-readable review, figures, reference index, PDF export, and machine-readable Evidence JSON download.
Evidence JSON can also be purchased separately if you only need the LLM-ready object for agent, AI, or RAG workflows.
Institutional or library access? Sign in with your institution email to open all available SAIMSARA papers under your institution access arrangement.
Need a SAIMSARA review on your own topic? ☸️Request.

Reference Index (121)

Unlock the full paper to view the complete Reference Index.

Article views: —
Follow us

© 2026 SAIMSARA Journal Impressum Published by ML in Health Science GbR